Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Torrent Pharma Appoints Former Cipla Global CTO Geena Malhotra as Chief Technology Officer

USFDA issues EIR for Torrent Pharma Dahej facility

Ruchika Sharma24 Aug 2023 1:30 PM IST

Ahmedabad: Torrent Pharmaceuticals Limited has announced that the US drug regulator US Food and Drug Administration (US FDA) has issued an...

JB Pharma secures USFDA nod for anxiety drug

Ruchika Sharma24 Aug 2023 12:30 PM IST

The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat.

AstraZeneca facing two London lawsuits over COVID vaccines

Ruchika Sharma24 Aug 2023 11:37 AM IST

The two cases are the first lawsuits brought in England and Wales over an adverse reaction to a COVID 19 vaccine, according to publicly available...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Concord Biotech gets USFDA EIR for Limbasi facility

Ruchika Sharma23 Aug 2023 3:30 PM IST

Ahmedabad: Through a recent BSE filing, Concord Biotech Limited has notified that the Company has received the Establishment Inspection...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche reports inadvertent disclosure in lung cancer immunotherapy study

Ruchika Sharma23 Aug 2023 2:30 PM IST

Basel: Roche announced today that it has been made aware of an inadvertent disclosure of the second interim analysis of the Phase III SKYSCRAPER-01...

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic elevates profit forecast as surgeries return to pre pandemic levels

Ruchika Sharma23 Aug 2023 1:30 PM IST

The Dublin based medical device maker now expects profit to be between USD 5.08 per share and USD 5.16 per share for the fiscal year 2024.

Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitis

Retevmo demonstrates superior progression free survival compared to approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer: Eli Lilly

Ruchika Sharma23 Aug 2023 12:30 PM IST

Retevmo is a highly selective and potent RET kinase inhibitor with CNS activity.

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb gets European Commission nod for Opdivo as adjuvant treatment for patients with completely Resected Stage IIB or IIC Melanoma

Ruchika Sharma23 Aug 2023 11:23 AM IST

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) as a monotherapy for the...

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Marksans Pharma Mucus loosening drug Guaifenesin ER bags USFDA okay

Ruchika Sharma22 Aug 2023 4:50 PM IST

Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus...

CDSCO Panel Flags Trial Death, Seeks Causality Report from Reliance Life Sciences on EtanerRel

ABB India bags order to automate Reliance Life Sciences biopharmaceutical facilities

Ruchika Sharma22 Aug 2023 4:00 PM IST

RLS' 160 acre facility at Nashik will house manufacturing plants for plasma proteins, biopharmaceuticals, oncology pharmaceuticals and vaccines.

Boehringer Ingelheim latest to sue US over drug price negotiation plan

Ruchika Sharma22 Aug 2023 3:00 PM IST

Type 2 diabetes treatment Jardiance, which Boehringer shares with US drugmaker Eli Lilly, is considered among the most likely drugs to be chosen for...

Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case Study

Glenmark, Teva to pay Rs 2118 crore over drug price-fixing

Ruchika Sharma22 Aug 2023 1:30 PM IST

Under the agreement, federal prosecutors will dismiss the charges in three years if the companies abide by the settlement terms.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok